Jeff Yass’s Vivos Therapeutics VVOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-536
Closed -$4.56K – 13250
2023
Q1
$4.56K Buy
+536
New +$11.7K ﹤0.01% 12314
2022
Q2
– Sell
-424
Closed -$28K – 14050
2022
Q1
$28K Buy
+424
New +$27.7K ﹤0.01% 12532
2021
Q4
– Sell
-3,100
Closed -$313K – 13995
2021
Q3
$313K Buy
+3,100
New +$326K ﹤0.01% 10511

Other funds holding VVOS

Jeff Yass's VVOS Position: Q3 2026 in Review

Jeff Yass increased its Vivos Therapeutics (VVOS) stake by 109% in Q3 2026, buying an estimated $3.31K and bringing the position to 21,087 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #13313.

Jeff Yass first reported a position in VVOS in Q3 2021 and has held it in 6 quarters since. The position peaked at $222K in Q3 2021. 27 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.

  • Jeff Yass held 21,087 shares of Vivos Therapeutics worth $3.12K as of Q3 2026.
  • Jeff Yass bought 11,012 Vivos Therapeutics shares in Q3 2026, an estimated $3.31K.
  • Vivos Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13313 holding.
  • Jeff Yass first reported a position in Vivos Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • Jeff Yass's Vivos Therapeutics position peaked at $222K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.